US Stock MarketDetailed Quotes

LYRA Lyra Therapeutics

Watchlist
  • 0.188
  • +0.001+0.70%
Close Jan 24 16:00 ET
  • 0.186
  • -0.001-0.64%
Post 20:01 ET
12.28MMarket Cap-0.13P/E (TTM)

About Lyra Therapeutics Company

Lyra Therapeutics, Inc. is a clinical-stage therapeutics company. It develops novel integrated drug and delivery solutions for the localized treatment of patients with ear, nose and throat, or ENT, diseases. The firms proprietary XTreo deliver medicines. The company was founded by Carmichael S. Roberts, George M. Whitesides, and Robert S. Langer in November 2005 and is headquartered in Watertown, MA.

Company Profile

SymbolLYRA
Company NameLyra Therapeutics
Listing DateMay 1, 2020
Issue Price16.00
Founded2005
CEODr. Maria Palasis, PhD
MarketNASDAQ
Employees145
Fiscal Year Ends12-31
Address480 Arsenal Way
CityWatertown
ProvinceMassachusetts
CountryUnited States of America
Zip Code02472
Phone1-617-393-4600

Company Executives

  • Name
  • Position
  • Salary
  • Dr. Maria Palasis, PhD
  • Director, President and Chief Executive Officer
  • 1.79M
  • Dr. Richard Nieman
  • Chief Medical Officer
  • --
  • Jason Cavalier
  • Chief Financial Officer, Treasurer and Principal Accounting Officer
  • --
  • Dr. Harlan W. Waksal,M.D.
  • Executive Chairman of the Board
  • 625.06K
  • James R. Tobin
  • Lead Independent Director
  • 152.31K
  • Dr. Nancy L. Snyderman, F.A.C.S.,M.D.
  • Independent Director
  • 109.06K
  • W. Bradford Smith
  • Independent Director
  • 123.81K
  • C. Ann Merrifield
  • Independent Director
  • 113.06K

Trending Stocks

Discussing
As Tesla's earnings near, will its stock soar?
🎙️Discussion: 1. With Trump's return, can Tesla's stock price continue to rise in 2025? 2. Tesla is set to release its earnings report aft Show More